Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) provided an update on the IONIS-TTRRx program. Ionis is currently evaluating IONIS-TTRRx in an ongoing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE